Exclusively Published

Maxim Remains Sidelined On Valeant Pharmaceuticals Intl Inc (VRX) Following Orkambi Europe Approval

In a research note issued Friday, Maxim analyst Jason McCarthy reiterated a Hold rating on shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), after the …

Chardan Capital Maintains Buy on StemCells Inc (STEM) Following Positive Interim Cervical Spine Data

In a research report issued today, Chardan Capital analyst Keay Nakae reiterated a Buy rating on shares of StemCells Inc (NASDAQ:STEM), with a price …

Pandora Media Inc (P) in Another Step Towards Platform Expansion: Canaccord

Canaccord analyst Michael Graham weighted in yesterday on Pandora Media Inc (NYSE:P), after the internet radio giant announced that it is acquiring on-demand music service Rdio …

Canaccord Reiterates Buy on Kite Pharma Inc Ahead of Upcoming Data Releases

In a research report released Friday, Canaccord analyst John Newman reiterated a Buy rating on shares of Kite Pharma Inc (NASDAQ:KITE) with a price …

Canaccord Reiterates Buy on Mast Therapeutics Inc Following 3Q:15 Update

In a research report issued Friday, Canaccord analyst John Newman reiterated a Buy rating on shares of Mast Therapeutics Inc (NYSEMKT:MSTX), with a $3.00 …

William Blair Remains Sidelined on Zogenix, Inc. Following 3Q:15 Update

In a research report released today, William Blair analyst Tim Lugo reiterated a Market Perform rating on shares of Zogenix, Inc. (NASDAQ:ZGNX), after the company reported …

Maxim Reiterates Buy on AEterna Zentaris Inc. (USA) Following 3Q Update

In a research report published Friday, Maxim Group analyst Jason Kolbert reiterated a Buy rating on shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) with …

Roth Capital Sets Expectations on InvenSense Inc (INVN) Ahead of Earnings

In a research report released Friday, Roth Capital analyst Krishna Shankar reiterated a Buy rating on shares of InvenSense Inc (NYSE:INVN), with a price …

Oppenheimer Reiterates Outperform on Zogenix, Inc. Following IND Update

In a research report issued yesterday, Oppenheimer analyst Akiva Felt reiterated an Outperform rating on shares of Zogenix, Inc. (NASDAQ:ZGNX) with a price target …